SAMANTHA BUSGITH: Open Payments
NPI 1801419684 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,287 in 62 payments from 15 companies in 2025. Trend: 2023 $961 · 2024 $1,031 · 2025 $1,287
Food & beverage: $1,287
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $313 |
| Arcutis Biotherapeutics, Inc. | 8 | $149 |
| PFIZER INC. | 6 | $128 |
| Novartis Pharmaceuticals Corporation | 6 | $126 |
| Organon LLC | 5 | $100 |
| UCB, Inc. | 4 | $98 |
| Amgen Inc. | 3 | $75 |
| Galderma Laboratories, L.P. | 2 | $72 |
| LEO Pharma Inc. | 2 | $54 |
| Janssen Biotech, Inc. | 2 | $43 |
Products named: RINVOQ, Zoryve, SKYRIZI, COSENTYX, Bimzelx, CIBINQO, Otezla, VTAMA.
Industry payments across NY — which companies pay providers there.
